SGN-CD33A COMBINED WITH HYPOMETHYLATING THERAPY PRODUCES HIGH REMISSION RATES AMONG OLDER PATIENTS WITH AML
Dr Amir Fathi (Abstract S503):
KILLER ANTIBODIES AGAINST AML
Dr Mette Hazenberg (Abstract S124):
IMPROVED SURVIVAL FOR ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS
Dr Nina Toft (Abstract LB173):
THE CLOT THICKENS
Dr Katherine A High (Abstract LB771):
GENOME SEQUENCING OF THOUSANDS OF PATIENTS WITH RARE BLOOD DISORDERS
Dr Ernest Turro (Abstract S518):
Refugees in 2016 - new hematological challenges
Dr Christine Chomienne, EHA President Elect: